EXIMMed Export-Import GmbH
Medical Technology · Düsseldorf
EXIMMed Export-Import GmbH is a medical technology company based in Düsseldorf, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
EXIMMed Export-Import GmbH Address & Contact
EXIMMed Export-Import GmbH Overview
EXIMMed Export-Import GmbH is a dynamic foreign trade company based in Düsseldorf, North Rhine-Westphalia, specializing in the international export and import of medical technology products. At a time when global supply chains are becoming increasingly complex, EXIMMed plays a crucial role in facilitating and coordinating trade relationships for medical products between German manufacturers and international markets. The company's expertise in regulatory and market requirements enables clients to efficiently and compliantly introduce their products to new markets.
Services and Products
EXIMMed offers a variety of services specifically designed to tackle the challenges of international trade in the field of medical technology. These include:
- Coordination of Export and Import Transactions: EXIMMed oversees the entire process from product selection to delivery to the target market, considering all relevant trade regulations.
- Customs Documentation: The company prepares all necessary customs documents, ensuring that the goods arrive on time and without delays.
- Regulatory Consulting: EXIMMed informs its partners about international regulations, approval processes, and quality standards that are crucial for successful market entry.
- Logistics Solutions: Through close cooperation with logistics companies, EXIMMed guarantees the efficient and secure transport of products worldwide.
- Market Research: Identifying trends and developments in various markets is essential for the successful positioning of products. EXIMMed provides comprehensive market analyses that serve as a basis for decision-making in market development.
These services not only ensure compliance with legal requirements but also significantly contribute to reducing time-to-market, which is of utmost importance in the fast-paced medical technology industry.
Regional Focus and Importance
Düsseldorf, as the location of EXIMMed, is not only geographically advantageous but also of outstanding economic significance. The city is home to numerous companies and institutions specialized in the health sector, including research institutions and universities. This concentration of expertise and innovation supports EXIMMed in establishing valuable partnerships.
The Rhine-Ruhr metropolitan region also provides access to one of the largest national healthcare markets in Europe. This region is known for its highly developed medical infrastructure, ensuring that EXIMMed has constant access to the latest developments and technologies in medical technology. Proximity to the international trade fair MEDICA allows the company to continuously stay informed about new trends and exchange ideas with leading experts in the industry.
Regulatory Classification and Compliance
An important aspect of EXIMMed's business operations is ensuring compliance with international standards and regulations in the field of medical technology. The company is committed to prioritizing product safety and quality at all times. Various guidelines, such as the Medical Devices Regulation (MDR) of the European Union, are thoroughly examined by EXIMMed to ensure that all products exported or imported meet stringent quality standards.
EXIMMed works closely with regulatory authorities to facilitate smooth product approvals for its clients. Careful documentation also plays a crucial role in this process. The company assists manufacturers in preparing the necessary technical documentation required to meet the requirements of the respective target markets.
Special Features of EXIMMed Export-Import GmbH
One of the particular strengths of EXIMMed lies in the individual customization of services to the specific needs of its partners. Each project is designed based on a detailed needs analysis and in coordination with the respective manufacturers to achieve the best possible results. This tailored approach allows EXIMMed to differentiate itself from other companies in the field of export-import and ensures high customer satisfaction.
In summary, it can be said that EXIMMed Export-Import GmbH occupies a key role in the international trade of medical technology products due to its in-depth industry knowledge, strategic location in Düsseldorf, and high compliance standards.
Other medical technology companies: Medical Technology Overview | Medical Technology North Rhine-Westphalia
Frequently asked questions about EXIMMed Export-Import GmbH
What does EXIMMed Export-Import GmbH do?
EXIMMed Export-Import GmbH is a company in the medical technology sector based in Düsseldorf. The company develops, manufactures or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is EXIMMed Export-Import GmbH based?
EXIMMed Export-Import GmbH is based in Düsseldorf. Detailed information can be found on the company website.
In which area of medical technology does EXIMMed Export-Import GmbH operate?
EXIMMed Export-Import GmbH operates in the medical technology sector and offers solutions for healthcare facilities, hospitals and practices. The exact areas of activity can be found on the company website.
More Medical Technology in Düsseldorf
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.